Login

Journal Image
Current Diabetes Reviews
ISSN (Print): 1573-3998
ISSN (Online): 1875-6417
VOLUME: 9
ISSUE: 6
DOI: 10.2174/15733998113096660083      Price:  $58









Intravitreal Injections and Diabetic Macular Edema: Actual and New Therapeutic Options

img
Author(s): Nicola Pescosolido, Federica Pranno and Giuseppe Buomprisco
Pages 491-498 (8)
Abstract:
The management of diabetic macular edema (DME) has been revolutionized in recent years. Focal and focal/ grid laser photocoagulation have been the mainstay of treatment for DME for much time. However, nowadays, there is growing evidence that intravitreal VEGF-inhibitors (combined or not with laser photocoagulation) provide better visual outcome in patients with diabetic retinopathy. Hence, anti-VEGF injections are considered the new gold standard to treat diabetic macular edema and eyes with a reduced visual function. Further studies assessing different treatment regimens are underway to define better clinical care pathways.
Keywords:
Anti-VEGF, diabetic macular edema, diabetes, neovascularization, rethinopathy, vision loss prevention.
Affiliation:
University “Sapienza” of Rome, Faculty of Medicine and Dentistry, Department of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, Viale del Policlinico 155, 00161, Rome, Italy.